Update shared on 10 Dec 2025
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.
What's in the News
- The board has scheduled a meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter ended September 30, 2025 (company filing).
- At the same meeting, the board will also consider the declaration of an interim dividend for the 2025–26 financial year (company filing).
Valuation Changes
- Fair Value: Unchanged at ₹653.25 per share, indicating no revision to the intrinsic value estimate.
- Discount Rate: Fallen slightly from 13.58 percent to about 13.53 percent, reflecting a marginally lower perceived risk profile.
- Revenue Growth: Effectively unchanged at around 9.18 percent, suggesting a stable outlook for topline expansion.
- Net Profit Margin: Flat at roughly 22.87 percent, indicating no material change in expected profitability levels.
- Future P/E: Eased slightly from about 37.66x to 37.61x, implying a marginally lower valuation multiple applied to forward earnings.
Have other thoughts on Emami?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.